Shire announces FDA approval of manufacturing facility for VPRIV Shire announced that the FDA has approved the production of VPRIV drug substance in Shire's manufacturing facility at 400 Shire Way, Lexington, Massachusetts, US. The facility was previously approved by the European Medicines Agency for production of VPRIV drug substance. Shire has invested over $200M in manufacturing infrastructure and technology to establish a consistent drug supply chain to patients that use this treatment.
News For SHPG From The Last 14 Days
Check below for free stories on SHPG the last two weeks.